Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
BioCryst (BCRX) has shared an announcement.
At BioCryst Pharmaceuticals’ Annual Meeting on June 12, 2024, stockholders passed several key proposals, including the expansion of the Stock Incentive Plan by 7 million shares. Additionally, three directors were elected, Ernst & Young LLP was ratified as the independent accountants for the year, and an advisory vote affirmed the company’s executive compensation. The decisions were made with a clear majority, showcasing stockholder support for the company’s strategic direction and governance.
For a thorough assessment of BCRX stock, go to TipRanks’ Stock Analysis page.
